Ginkgo Bioworks Holdings (DNA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NYSE
Market Cap: $622.97M
Last updated: Nov 17, 2026 at 4:37 PM ET
Ginkgo Bioworks Holdings (DNA) Stock Chart
Ginkgo Bioworks Holdings (DNA) has a latest price of $8.31 on Nov 17, 2026, 54.4% below its 52-week high of $18.22. Its price rose 3.5% over the past 12 months. The month-end price fell 98.0% over the 5 years through Oct 2026, a compound annual decline of 54.1%.
Price Chart
From Apr 2021 to Oct 2026, its highest month-end close was $552.80 in Oct 2021 and its lowest $5.70 in Mar 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DNA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DNA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 7.8%, and over 6 months it rose 13.0%. The month-end price fell 79.5% over the 3 years through Oct 2026, a compound annual decline of 41.1%.
| Period | Change |
|---|---|
| 1 month | -17.4% |
| 3 months | +7.8% |
| 6 months | +13.0% |
| 12 months | +3.5% |
| 12 months, with dividends | +3.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -79.5% | -41.1% |
| 5 years | -98.0% | -54.1% |
Price by Year
Its best calendar year was 2023, when the price was flat, and its weakest was 2024, when it fell 85.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $11.21 | +34.9% |
| 2025 | $8.31 | -15.4% |
| 2024 | $9.82 | -85.5% |
| 2023 | $67.60 | 0.0% |
| 2022 | $67.60 | -79.7% |
Trading Range
The price is 19.6% below its 50-day average of $10.35 and 3.7% below its 200-day average of $8.63.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $8.31 | |
| 52-week high | $18.22 | -54.4% |
| 52-week low | $5.37 | +54.8% |
| 50-day average | $10.35 | -19.6% |
| 200-day average | $8.63 | -3.7% |
Price Risk
Over 3 years, its largest fall from a peak was 92.5%.
| Measure | Value |
|---|---|
| 1-year beta | 3.31 |
| Largest fall, 1 year | -48.8% |
| Largest fall, 3 years | -92.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DNA
What is DNA's 1-year price change?
Ginkgo Bioworks Holdings's price rose 3.5% over the past 12 months. With dividends included, the 12-month total return was 3.5%.
What is DNA's 5-year price change?
Ginkgo Bioworks Holdings's month-end price fell 98.0% over the 5 years through Oct 2026, a compound annual decline of 54.1%. These figures leave out dividends.
What is DNA's 52-week high and low?
Ginkgo Bioworks Holdings's 52-week high is $18.22 and its 52-week low is $5.37. Its latest price of $8.31 on Nov 17, 2026 is 54.4% below the high.
What is DNA's beta?
Ginkgo Bioworks Holdings's 1-year beta against the S&P 500 is 3.31, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 48.8%.
Is the DNA chart free?
Yes. Advanced Charting for DNA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DNA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts